UAB Comprehensive Cancer Center
				
				
          
			          One of the nation’s leading cancer research and treatment centers, the UAB Comprehensive Cancer Center is the only National Cancer Institute-designated comprehensive cancer center located in a six-state area that includes Alabama, Mississippi, Louisiana, Arkansas, South Carolina and Georgia. UAB’s cancer services are routinely recognized as being among the nation’s best.
The UAB Comprehensive Cancer Center is home to an outstanding faculty of more than 330 physicians and researchers, many of whom are internationally and nationally recognized for their expertise in oncology. The center treats an estimated 5,000 new patients each year.
We've found
        16 trials
        at this facility
      	
	Oncology Clinical Trial
	
Updated: 10/11/2012
  
  
  Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
		Status: Enrolling	
	Updated: 10/11/2012
Click here to add this to my saved trials
	    
		
	Brain and Central Nervous System Tumors Clinical Trial
	
Updated: 5/1/2012
  
  
  Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
		Status: Enrolling	
	Updated: 5/1/2012
Click here to add this to my saved trials
	    
		
	Hematology, Oncology Clinical Trial
	
Updated: 7/12/2012
  
  
  MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
		Status: Enrolling	
	Updated: 7/12/2012
Click here to add this to my saved trials
	    
		
	Sarcoma Clinical Trial
	
Updated: 6/23/2014
  
  
  Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 6/23/2014
Click here to add this to my saved trials
	    
		
	Breast Cancer Clinical Trial
	
Updated: 12/6/2012
  
  
  Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/6/2012
Click here to add this to my saved trials
	    
		
	Hematology, Oncology Clinical Trial
	
Updated: 1/29/2014
  
  
  INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 1/29/2014
Click here to add this to my saved trials
	    
		
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Endocrine Response in Women With Invasive Lobular Breast Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Breast Cancer Clinical Trial
	
Updated: 4/10/2010
  
  
  Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling	
	Updated: 4/10/2010
Click here to add this to my saved trials
	    
		
	Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
	
Updated: 8/3/2012
  
  
  Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
		Status: Enrolling	
	Updated: 8/3/2012
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/5/2012
  
  
  Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
		Status: Enrolling	
	Updated: 12/5/2012
Click here to add this to my saved trials
	    
		
	Hematology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of the Effect IL 7/ NT-I7 on CD4 Counts in Patients With High Grade Gliomas
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Colorectal Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 10/11/2012
  
  
  Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 10/11/2012
Click here to add this to my saved trials
	    
		
	Leukemia Clinical Trial
	
Updated: 7/24/2014
  
  
  Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 7/24/2014
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Oncology Clinical Trial
	
Updated: 10/11/2012
  
  
  Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
		Status: Enrolling	
	Updated: 10/11/2012
Click here to add this to my saved trials